NEULASTIM
Brand:
NEULASTIM
Manufacturer:
ROCHE
Manufacturer Details
ROCHE
ROCHE SCIENTIFIC COMPANY
63/12- A RAMA ROAD
INDUSTRIAL AREA
NAJAFGARH ROAD
NEW DELHI 110015
Compositions:
Pegfilgrastim 6mg/vial injection,
Strength
|
Rate
|
Packing Style
|
6mg/ml
|
33800.00
|
1 vial injection
|
List of Related Indications:
- Reduction duration of neutropenia due cytotoxic chemotherapy
List Of Drugs:
- Pegfilgrastim- Colony Stimulating Factors- Hematopoietic Agents
Indication Type Description:
Drug Interaction:
Antimetabolites Radiotherapy Thrombocytopaenic drugs Lithium Bone imaging results
Indication:
Reduction in duration of neutropenia and incidence of febrile neutropenia dure to chemotherapy
Adverse Reaction:
Skeletal joint and muscle pain Inj. site pain Non-cardiac chest pain Headache Splenomegaly Splenic rupture Leucocytosis ARDS Anaphylaxis Angioedema Urticaria Reversible elevated uric acid Alkaline phosphatase and lactate dehydrogenase
Contra-Indications:
Hypersensitivity to E.Coli derived products Secondary acute or chronic myeloid leukemia Myledysplastic syndrome Lactation Special precautions- Use undrer specialised supervision Acute leukemia patients receiving mylesuppresive chemotherapy High-dose chemotherapy Discontinue if signs of adult respiratory distress syndrome Monitor CBC and platelet count before and during thderapy for signs of splenic rupture Sickle cell disease Sepsis Moderate to severe organ impairment Pregnancy
Dosages/ Overdosage Etc:
Reduction in duration of neutropenia and incidence of febrile neutropenia dure to Chemotherapy
Dosage-
Single 6mg sc injection for each chemotherapy cycle given approx. 24 hours following chemotherapy Not recommended for patients belw 18 years
Pregnancy and lactation:
Use contraindicated. Observe caution